Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Clinical trial NCT02736162 · COMPLETED

Trial details

NCT number: NCT02736162
Sponsor: Eisai Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Epilepsy Partial-Onset Seizures Primary Generalized Tonic-Clonic Seizures

Start date: 2016-04-01
Primary completion: 2016-06-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.